Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
Spironolactone (SPR) has been shown to protect diabetic cardiomyopathy (DCM), but the specific mechanisms are not fully understood. Here, we determined the cardioprotective role of SPR in diabetic mice and further explored the potential mechanisms in both in vivo and in vitro models. Streptozotocin-...
Saved in:
Main Authors: | Wenjuan Liu, Wei Gong, Min He, Yemei Liu, Yeping Yang, Meng Wang, Meng Wu, Shizhe Guo, Yifei Yu, Xuanchun Wang, Fei Sun, Yiming Li, Linuo Zhou, Shengmei Qin, Zhaoyun Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2018/9232065 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effects of MicroRNAs on Cardiomyopathy in a Rat Model of Streptozotocin-induced Diabetes Mellitus
by: Aslıhan Şeyda DOĞAN, et al.
Published: (2025-01-01) -
Morphological Changes of Gingiva in Streptozotocin Diabetic Rats
by: C. Tesseromatis, et al.
Published: (2009-01-01) -
Anti-hyperglycemic effects of dihydromyricetin in streptozotocin-induced diabetic rats
by: Maojun Yao, et al.
Published: (2021-03-01) -
Intermittent Fasting Modulation of the Diabetic Syndrome in Streptozotocin-Injected Rats
by: Louiza Belkacemi, et al.
Published: (2012-01-01) -
Inhibitory Effect of r-Hirudin Variant III on Streptozotocin-Induced Diabetic Cataracts in Rats
by: Xiaojian Gong, et al.
Published: (2013-01-01)